Search Tag: Pancreatic Stone Protein

ICU Management

Volume 23 - Issue 1, 2023

2023 13 Mar

Change content default value Read more


Nanofluidic Technology Enables Rapid Quantification of PSP as an Early Biomarker of Sepsis

2023 01 Feb

In-vitro diagnostic tests allow for quick results and prompt decision-making by medical professionals in near-patient settings. The abioSCOPE® device uses nanofluidic technology to quickly measure the number of molecules in a sample using a small amount of fluid and minimal preparation, resulting in fast results. Pancreatic stone protein (PSP) is a... Read more

ICU Management

Guiding Clinical Care Using Pancreatic Stone Protein

2022 08 Dec

The role of point-of-care testing in the early identification and management of sepsis, the need for better markers to identify sepsis, an overview of the Pancreatic Stone Protein (PSP) and clinical evidence highlighting its effectiveness as a biomarker. Pancreatic Stone Protein Infections are a leading cause of morbidity and mortality... Read more


Pancreatic Stone Protein for Predicting Perioperative Infection in Cardiac Surgery

2022 06 Dec

According to the Surviving Sepsis Campaign (SSC), sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. The organ dysfunction may be transitory in some patients, but complications can always occur in others. For example, a patient who has undergone cardiac surgery can present postoperative cardiac dysfunction,... Read more


AMR Dilemma: To Give or Not to Give Antibiotics

2022 24 Nov

The two primary reasons for using antibiotics are treating and preventing bacterial infections. However, a leading cause of the overuse of antibiotics is the misdiagnosis of sepsis. Early and accurate diagnostics using point-of-care biomarkers can help address this issue.  Sepsis is a dysregulated reaction of the body to infection. It is a significant... Read more


Abionic Webinar – Guiding Clinical Care Using Pancreatic Stone Protein

2022 18 Oct

The role of Point-of-Care Testing in the Early Identification and Management of Sepsis   Introduction & Welcome On September 22nd, over 240 attendees from all over the world had the opportunity to connect and tune into this educational session along with interactive roundtable discussions, chaired and moderated by Prof. Jean-Louis Vincent,... Read more

ICU Management

Abionic Receives IVDR Certification for Its Predictive Ultra-Rapid Sepsis Test

2022 09 Aug

BSI certification agency has granted Abionic’s abioSCOPE® device and PSP test the IVDR certification for in-vitro diagnostics. This certification complies with Europe’s new In-vitro Diagnostic Regulation (IVDR), and will be required for products sold within the EU from May 2022 onward. A transitional regulation allows established, non-IVDR-certified... Read more


Pancreatic Stone Protein Testing Reduces Expenditure in Sepsis

2022 02 Aug

Sepsis is a life-threatening organ dysfunction and a cause of significant morbidity and mortality. In addition, the high number of sepsis cases is a significant economic burden for healthcare systems. Statistics show that sepsis was the most expensive condition treated in the U.S. in 2013, costing nearly $24 billion. An analysis of Medicare claims... Read more


Accuracy of Pancreatic Stone Protein for Diagnosis of Infection

2022 12 Jul

Severe infections cause significant morbidity and mortality among hospitalised patients. Early detection of life-threatening infections is crucial to improving outcomes. However, none of the circulating blood biomarkers that have been investigated have been found to detect life-threatening infection quickly or accurately. Despite sub-optimal results,... Read more